Neuroimaging biomarkers for Parkinson disease: facts and fantasy.


In this grand rounds, we focus on development, validation, and application of neuroimaging biomarkers for Parkinson disease (PD). We cover whether such biomarkers can be used to identify presymptomatic individuals (probably yes), provide a measure of PD severity (in a limited fashion, but frequently done poorly), investigate pathophysiology of parkinsonian… (More)
DOI: 10.1002/ana.24291


  • Presentations referencing similar topics